{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:30:07Z","timestamp":1793500207296,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["68155"],"award-info":[{"award-number":["68155"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011556","name":"Conseil Sup\u00e9rieur de la P\u00eache","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP19201"],"award-info":[{"award-number":["GGP19201"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["874700"],"award-info":[{"award-number":["874700"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jtha.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T21:13:12Z","timestamp":1741813992000},"page":"3466-3480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factor VIII, a coagulation cofactor, is a relevant survival factor in bladder cancer cell lines"],"prefix":"10.1016","volume":"23","author":[{"given":"Gillian E.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rida","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Olgasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Borsotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9780-300X","authenticated-orcid":false,"given":"Antonia","family":"Follenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.03.002_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13045-020-00932-z","article-title":"Beyond thrombosis: the impact of tissue factor signaling in cancer","volume":"13","author":"Unruh","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtha.2025.03.002_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11239-022-02662-0","article-title":"Tissue factor: a neglected role in cancer biology","volume":"54","author":"Li","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.03.002_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40364-023-00504-6","article-title":"Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer","volume":"11","author":"Ahmadi","year":"2023","journal-title":"Biomark Res"},{"key":"10.1016\/j.jtha.2025.03.002_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jth.15611","article-title":"Factor VIII as a potential player in cancer pathophysiology","volume":"20","author":"Walker","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.002_bib5","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood.V92.11.3983","article-title":"The life cycle of coagulation factor VIII in view of its structure and function","volume":"92","author":"Lenting","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.002_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A","volume":"5","author":"Lakich","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2025.03.002_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.blre.2019.03.002","article-title":"Factor VIII: long-established role in haemophilia A and emerging evidence beyond haemostasis","volume":"35","author":"Samuelson Bannow","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2025.03.002_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1676796","article-title":"Macrophage polarization is deregulated in haemophilia","volume":"119","author":"Knowles","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.002_bib9","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/bloodadvances.2018018226","article-title":"A cross-sectional analysis of cardiovascular disease in the hemophilia population","volume":"2","author":"Sood","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.03.002_bib10","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3324\/haematol.2024.285089","article-title":"Factor VIII promotes angiogenesis and vessel stability regulating extracellular matrix proteins","volume":"109","author":"Olgasi","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.03.002_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bjh.13312","article-title":"Increased fracture rates in people with haemophilia: a 10-year single institution retrospective analysis","volume":"170","author":"Gay","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.03.002_bib12","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.M109.030312","article-title":"Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival","volume":"284","author":"Baud'huin","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.03.002_bib13","first-page":"3661","article-title":"Factor VIII plays a direct role in osteoblast development","volume":"130","author":"Larson","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.002_bib14","first-page":"259","article-title":"HIV-based vectors. Preparation and use","volume":"69","author":"Follenzi","year":"2002","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.jtha.2025.03.002_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.biopha.2016.12.070","article-title":"CREB knockdown inhibits growth and induces apoptosis in human pre-B acute lymphoblastic leukemia cells through inhibition of prosurvival signals","volume":"87","author":"Shabestari","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtha.2025.03.002_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108834","article-title":"Integrin \u03b21 coordinates survival and morphogenesis of the embryonic lineage upon implantation and pluripotency transition","volume":"34","author":"Mol\u00e8","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtha.2025.03.002_bib17","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jclinpath-2013-202163","article-title":"Overexpression of integrin \u03b1v correlates with poor prognosis in colorectal cancer","volume":"67","author":"Ha","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jtha.2025.03.002_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75085-7","article-title":"Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival","volume":"10","author":"Loeser","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2025.03.002_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.01.002","article-title":"Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer","volume":"187","author":"Moik","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.03.002_bib20","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1538-7836.2011.04505.x","article-title":"Functional factor VIII made with von Willebrand factor at high levels in transgenic milk","volume":"9","author":"Pipe","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.002_bib21","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/ATVBAHA.109.190827","article-title":"High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study","volume":"29","author":"Vormittag","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.03.002_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.thromres.2020.09.021","article-title":"High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: the Thrombo-NSCLC risk score","volume":"196","author":"Castell\u00f3n Rubio","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.03.002_bib23","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1091\/mbc.e03-09-0640","article-title":"Cross-talk of integrin alpha3beta1 and tissue factor in cell migration","volume":"15","author":"Dorfleutner","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jtha.2025.03.002_bib24","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1038\/s41388-022-02511-7","article-title":"Integrin regulation by tissue factor promotes cancer stemness and metastatic dissemination in breast cancer","volume":"41","author":"\u00dcnl\u00fc","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jtha.2025.03.002_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1160\/TH03-08-0549","article-title":"The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells","volume":"92","author":"Wiiger","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.002_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10495-020-01611-7","article-title":"Activation of beta1 integrins and caveolin-1 by TF\/FVIIa promotes IGF-1R signaling and cell survival","volume":"25","author":"\u00c5berg","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.jtha.2025.03.002_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/hae.14078","article-title":"Biological mechanisms underlying inter-individual variation in factor VIII clearance in haemophilia","volume":"26","author":"Turecek","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.03.002_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jtha.2025.03.002_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1083\/jcb.134.3.793","article-title":"Control of adhesion-dependent cell survival by focal adhesion kinase","volume":"134","author":"Frisch","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jtha.2025.03.002_bib30","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.jtha.2023.09.004","article-title":"Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo","volume":"21","author":"Cao","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.002_bib31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0021-9258(17)35234-1","article-title":"Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor","volume":"266","author":"Leyte","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.03.002_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00227-8","article-title":"Coagulation factor VIII: structure and stability","volume":"259","author":"Wang","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtha.2025.03.002_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.thromres.2012.09.011","article-title":"Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII","volume":"131","author":"Kannicht","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.03.002_bib34","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood-2008-05-158584","article-title":"Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress","volume":"113","author":"Huang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116516","article-title":"Vascular endothelial-derived Von Willebrand factor inhibits lung cancer progression through the \u03b1v\u03b23\/ERK1\/2 axis","volume":"468","author":"Lu","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jtha.2025.03.002_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41389-017-0023-5","article-title":"Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma","volume":"7","author":"Yang","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jtha.2025.03.002_bib37","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/cas.15298","article-title":"Lung adenocarcinoma-derived vWF promotes tumor metastasis by regulating PHKG1-mediated glycogen metabolism","volume":"113","author":"Gu","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jtha.2025.03.002_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115927","article-title":"Breast cancer cells-derived von Willebrand factor promotes VEGF-A-related angiogenesis through PI3K\/Akt-miR-205-5p signaling pathway","volume":"440","author":"Tao","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jtha.2025.03.002_bib39","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.2019000510","article-title":"The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing","volume":"133","author":"Ishihara","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.002_bib40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bjh.16311","article-title":"Factor VIII: the protein, cloning its gene, synthetic factor and now - 35 years later - gene therapy; what happened in between?","volume":"189","author":"Ling","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.03.002_bib41","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.83.16.5939","article-title":"A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity","volume":"83","author":"Toole","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.03.002_bib42","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/jth.14204","article-title":"In-depth comparison of N-glycosylation of human plasma-derived factor VIII and different recombinant products: from structure to clinical implications","volume":"16","author":"Canis","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.002_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233576","article-title":"Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII","volume":"15","author":"Qu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.03.002_bib44","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1074\/jbc.273.14.8537","article-title":"Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin","volume":"273","author":"Pipe","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.03.002_bib45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1538-7836.2005.01389.x","article-title":"The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor","volume":"3","author":"Bovenschen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.03.002_bib46","doi-asserted-by":"crossref","first-page":"10760","DOI":"10.1021\/bi970052+","article-title":"The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding","volume":"36","author":"Li","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2025.03.002_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11095-019-2599-2","article-title":"How full-length FVIII benefits from its heterogeneity - insights into the role of the B-domain","volume":"36","author":"Anzengruber","year":"2019","journal-title":"Pharm Res"},{"key":"10.1016\/j.jtha.2025.03.002_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.mbc.0000233368.95733.3c","article-title":"Role of the B domain in proteolytic inactivation of activated coagulation factor VIII by activated protein C and activated factor X","volume":"17","author":"Khrenov","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2025.03.002_bib49","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1182\/blood.V84.12.4214.bloodjournal84124214","article-title":"Role of the B domain for factor VIII and factor V expression and function","volume":"84","author":"Pittman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.002_bib50","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1021\/bi00374a001","article-title":"Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule","volume":"25","author":"Eaton","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2025.03.002_bib51","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1074\/jbc.270.8.3648","article-title":"The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII","volume":"270","author":"Donath","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.03.002_bib52","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V81.11.2925.2925","article-title":"Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII","volume":"81","author":"Pittman","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.03.002_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130501","article-title":"The role of proteolytic cleavage at Arg336 and Arg372 of the A1 domain in factor VIIa\/tissue factor-catalyzed reactions of B domain-deleted factor VIII","volume":"1868","author":"Nakajima","year":"2024","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.jtha.2025.03.002_bib54","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2516.2009.02026.x","article-title":"Functional roles of the factor VIII B domain","volume":"15","author":"Pipe","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.03.002_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2025.03.002_bib56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2025.03.002_bib57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12609","article-title":"Understanding cell cycle and cell death regulation provides novel weapons against human diseases","volume":"281","author":"Wiman","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.jtha.2025.03.002_bib58","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625001424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:27:08Z","timestamp":1793500028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625001424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1538783625001424"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.03.002","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor VIII, a coagulation cofactor, is a relevant survival factor in bladder cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}